The KEGG bladder cancer pathway activation in poor prognosis CRCs was mostly due to increased expression of functional nodes HRAS/KRAS/NRAS, ARAF/BRAF/RAF1, MAPK1/MAPK3, and RPS6KA5 (Fig. 3 A-C). The gene discussed is HRAS; the disease is urinary bladder cancer.